Creating therapies for Alzheimer's disease by targeting neural circuits
Study finds a complex series of molecular, cellular, circuit and network-level changes contribute to the progression of Alzheimer's.
Study finds a complex series of molecular, cellular, circuit and network-level changes contribute to the progression of Alzheimer's.
In clinical trial, mixture developed at MIT appears to help overcome loss of connections between brain cells.